Horizon Technology Finance Corporation (NASDAQ: HRZN) is a business development company that provides secured venture debt and growth capital to venture capital-backed companies in the technology, life sciences, and healthcare sectors. The team has originated and invested over $3.8 billion since 2004.
31% of their portfolio is in Healthcare. Average disclosed round size is $30.9M (across 23 rounds with reported amounts).
Portfolio
21
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Team
Kevin J. May
Head of Originations, Senior Vice President & Senior Managing Director
Mishone B. Donelson
Head of Life Science Lending, Senior Vice President & Senior Managing Director
Todd Jaquez-Fissori
Senior Managing Director
Todd A. McDonald
Head of Technology Lending and Senior Managing Director
Danny Hurwitz
Managing Director
Garrett Edson
Managing Director
Megan N. Bacon
Director of Investor Relations and Marketing
Charles T. LeFevre
Assistant Vice President - Credit
Connor Lockhart
Vice President - Credit
Dan Trolio
Executive Vice President & CFO
Daniel R. Trolio
Executive Vice President and Chief Financial Officer
Eric Tkacz
Vice President of Operations
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 GT Medical Technologies | Unknown | $35M | Sep 2024 |
 Everstream | Series B | $50M | Apr 2023 |
 Robin Healthcare | Unknown | — | Oct 2022 |
| MMyForest Foods | Series A | $15M | Apr 2022 |
 Canary Medical | Unknown | $20M | Jan 2021 |
 Engage3 | Series D | $35M | Jan 2021 |
 CVRx | Unknown | $50M | Jul 2020 |
 Avalanche Technology | Series D | $30M | Aug 2012 |
| Avalanche Technology | Unknown | $33M | Jul 2012 |
| Avalanche Technology | Series C | $11.5M | Jan 2012 |
 Education Elements | Seed | $6M | Jan 2012 |
| PPixelOptics | Unknown | $45M | Apr 2011 |
| Avalanche Technology | Series B | $7.5M | Feb 2010 |
| EEnphase | Bridge | $40M | Jan 2010 |
| AAnacor Pharmaceuticals | Unknown | $50M | Jan 2009 |
 Liqid | Series C | $100M | — |
 Samba TV | Debt | $60M | — |
| Engage3 | Series C | $12M | — |
 Cognoa | Unknown | $11.6M | — |
 Sonex Health | Series B | — | — |
| Sonex Health | Series A | — | — |
 Corinth MedTech | Series D | $12M | — |
 Revinate | Series C | $13.0M | — |
 Ossio | Series C | $35M | — |
 Precision Therapeutics | Unknown | $35M | — |
Top Co-Investors
Last updated: 8 September 2026